- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03738787
Treatment of the Pancreatic Stump With Neoprene®-Based Glue After High-risk Pancreatoduodenectomy
Efficacy and Safety of Exocrine Pancreatectomy With Neoprene®-Based Glue After High-risk Pancreatoduodenectomy (PD) in Patients With Pancreatic, Papilla, Duodenal, and Distal Choledochus Neoplasm
Study Overview
Status
Intervention / Treatment
Detailed Description
Although improved in many aspects, the PD intervention is still burdened by a significant morbidity, related above all to the delicate phase following the removal of the tumor which involves the reconstruction of the gastro-enteric, biliary and especially pancreatic pathway. Among the many variants of the reconstructive phase, that of pancreato-jejunal anastomosis is the one burdened by the highest complication rate (quantified around 40%, with a percentage of pancreatic fistula between 5% and 35%).
In cases at risk of pancreatic fistula it is possible not to perform a conventional pancreato-jejunal anastomosis, but to decide to inject into the pancreatic stump the solidifying glues with the aim of inducing a chemical pancreatectomy of the exocrine component of the pancreas.
Neoprene® (Polychloroprene) has the property of polymerizing and solidifying in an environment with a pH lower than its own (pH <12).
After a systematic review of the sporadic experiences of chemical pancreatectomy published until today, due to the increased complexity of the surgical cases of patients undergoing PD, the investigators have undertaken a formal, single-center prospective study, aimed at clarifying the safety and efficacy data of a Neoprene®-based glue in patients selected through objective criteria (such as the high risk of pancreatic fistula and early tumor recovery after pancreatoduodenectomy).
In this study is expected the prospective collection of a cohort of patients with tumor of the head of the pancreas, papilla, duodenum and distal choledochus to undergo pancreatoduodenectomy (PD) at high risk of pancreatic fistula and / or local recurrence ("Study Arm").
At the same time a second cohort of patients with the same type of neoplasia will be collected, subjected to PD intervention in which however it will be possible to proceed with pancreato-jejunal anastomosis. This group will be defined as "Control Arm".
The first cohort will be the group of patients in which to detect the safety and efficacy of the treatment with Neoprene®-based glue.
The second cohort will be the comparative control group against which patients treated with Neoprene®-based glue can be compared in the hypothesis that peri-operative morbidity,mortality and short and long-term side effects of the intervention are equivalent.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Milano, Italy, 20133
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with an alternative-Fistula Risk Score >15%.
- Patients with insulin-dependent diabetes.
- Cirrhotic patients or with histologically proven chronic liver disease.
- Age> 75 years (relative criterion, ie insufficient by itself to justify the procedure and therefore to be associated with one of the other cited criteria).
- Patients with intraoperative demonstration on histological examination of lymph node metastasis;
- Patients with R1 interventions.
- Presence of minimal extra-pancreatic tumor disease not detected pre-operatively (nodule of carcinosis, single liver metastasis) and removed with the primary tumor within the same intervention;
- Patients undergoing preoperative radiotherapy / chemotherapy for tumors reconverted to surgical operability.
Exclusion Criteria:
- All other patients who undergo PD in which the eligibility conditions for the study group are not present, are enrolled in the Control Arm..
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Pancreatic duct occlusion
Patients considered at high risk for pancreatic fistula or oncological relapse due to introperative evaluation submitted to pancreatic duct occlusion with Neoprene-based glue.
|
Pancreatic duct occlusion of the pancreatic stump with Neoprene-based glue after Pancreatoduodenectomy.
|
ACTIVE_COMPARATOR: Pancreato-Jejunal anastomosi
Patients considered at low risk for pancreatic fistula submitted to pancreato-jejunal anastomosis.
|
Standardized pancreato-jejunal anastomosis after Pancreatoduodenectomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of postoperative complications of grade > II according to Dindo-Clavien classification
Time Frame: 90 days
|
Comparison of 90-days clinically relevant postoperative morbidity rate of grade > II according to Dindo-Clavien classification between the two arms.
|
90 days
|
Rate of overall postoperative complications
Time Frame: 90 days
|
Comparison of 90-days overall postoperative morbidity rate of any grade according to Dindo-Clavien classification between the two arms.
|
90 days
|
Rate of postoperative mortality
Time Frame: 90 days
|
Comparison of 90-days postoperative mortality rate between the two arms
|
90 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants with onset of post-surgical diabetes
Time Frame: 12 months
|
Comparison between arms of onset of newly diagnosed post-surgical diabetes needing tablets or insulin therapy during a follow-up period of 12 months
|
12 months
|
Percentual variation of weight after pancreatoduodenectomy
Time Frame: 12 months
|
Comparison between arms of percentual weight variation between preoperative measure in kilograms and follow up at 1, 3, 6 and 12 months
|
12 months
|
Variation of Body Mass Index after pancreatoduodenectomy
Time Frame: 12 months
|
Comparison between arms of Body Mass Index variation measured combining weight and height to report BMI in kg/m^2 between preoperative evaluation and follow up at 1, 3, 6 and 12 months
|
12 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Overall survival
Time Frame: 36 months
|
Evaluation of overall survival in both arms of study
|
36 months
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pathologic Processes
- Neoplasms by Site
- Endocrine System Diseases
- Digestive System Neoplasms
- Endocrine Gland Neoplasms
- Pathological Conditions, Anatomical
- Pancreatic Diseases
- Digestive System Fistula
- Neoplasms
- Fistula
- Pancreatic Neoplasms
- Postoperative Complications
- Pancreatic Fistula
Other Study ID Numbers
- 191/14
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Complications
-
Marmara UniversityHacettepe University; Cukurova University; Gazi University; Baskent University; Istanbul... and other collaboratorsNot yet recruitingComplications, PostoperativeTurkey
-
Syed HusainRecruitingComplications, PostoperativeUnited States
-
Vastra Gotaland RegionRecruitingSurgery | Lung Infection | Complications, PostoperativeSweden
-
University of PittsburghCompletedLiver Transplant; Complications | Perioperative/Postoperative ComplicationsUnited States
-
Washington University School of MedicineNational Institute of Nursing Research (NINR)CompletedSurgery | Surgery--Complications | Perioperative/Postoperative ComplicationsUnited States
-
Wake Forest University Health SciencesTerminatedPerioperative/Postoperative ComplicationsUnited States
-
Technical University of MunichHealth Information Management, BelgiumActive, not recruitingPerioperative/Postoperative Complications
-
Atatürk Chest Diseases and Chest Surgery Training...CompletedPerioperative/Postoperative ComplicationsTurkey
-
Namigar TurgutCompletedPerioperative/Postoperative ComplicationsTurkey
-
TC Erciyes UniversityCompletedPerioperative/Postoperative ComplicationsTurkey
Clinical Trials on Pancreatic duct occlusion with Neoprene
-
Instituto Ecuatoriano de Enfermedades DigestivasActive, not recruitingBiliary Tract DiseasesEcuador
-
Second Affiliated Hospital, School of Medicine,...Ningbo No. 1 Hospital; Huizhou Municipal Central Hospital; Taizhou Hospital of... and other collaboratorsRecruiting
-
AdventHealthCompletedWalled Off Necrosis | Necrotizing PancreatitisUnited States
-
Changhai HospitalEnrolling by invitationChronic PancreatitisChina
-
University Hospital Schleswig-HolsteinWithdrawnChronic Acute PancreatitisGermany
-
Seoul National University HospitalCompletedPancreatic FistulaKorea, Republic of
-
Washington University School of MedicineNorthwestern University; University of OklahomaCompletedEndoscopic Retrograde Cholangiopancreatography (ERCP) | Bile Duct CannulationUnited States
-
Shanghai Zhongshan HospitalRenJi Hospital; First Affiliated Hospital Xi'an Jiaotong University; The Affiliated... and other collaboratorsNot yet recruiting
-
Johns Hopkins UniversityWithdrawnPancreatic CancerUnited States
-
Karolinska University HospitalUniversity Hospital, Linkoeping; Lund University Hospital; Sahlgren´s University... and other collaboratorsUnknownHealing Time of Post Operative Pancreatic FistulasSweden